By providing insight into the direct and patient-specific effects of anaesthesia on the brain, the BIS™ brain monitoring system helps clinicians determine and administer the precise amount of drug to meet the needs of each individual patient, leading to increased patient anaesthesia satisfaction.
Bispectral Index™ (BIS™) technology was the first clinically proven and commercially available direct measure of the effects of anaesthetics and sedatives on the brain.
BIS™ technology enables medical professionals to reliably gauge the precise amount of anaesthetic medication required by each patient, resulting in better overall patient care.
- Author George Mashour, et al., in a clinical review on the prevention of intraoperative awareness with explicit recall.
- Authors Yodying Punjasawadwong, Aram Phongchiewboon, and Nutchanart Bunchungmongkol, in a clinical review of bispectral index for improving anaesthetic delivery and postoperative recovery.